-
In recent months, Bausch + Lomb reported solid quarterly results while facing pressure on free cash flow and carrying a sizeable debt load that could constrain financial flexibility.
-
A separate update revealed Bausch + Lomb has partnered with Coursera to roll out mandatory generative AI training to about 8,000 knowledge workers, tying course completion to employee bonuses to accelerate AI adoption across its operations.
-
We’ll now examine how the company’s mandatory Coursera-led AI program may influence Bausch + Lomb’s existing investment narrative and long-term execution.
Find 54 companies with promising cash flow potential yet trading below their fair value.
To own Bausch + Lomb, you need to believe its broad eye health portfolio can convert steady revenue growth into sustainable earnings and healthier cash generation. The Coursera-led AI rollout may support execution over time, but it does not change the near term focus on stabilizing free cash flow and managing a sizeable debt load, which remains the key financial risk and the most important near term item to watch.
Among recent updates, the large scale refinancing of about US$2.8 billion of term loans stands out here, as it resets maturities and slightly lowers interest margins. For a company burning cash and already highly leveraged, this financing move is more immediately relevant to the investment case than the AI program, because it directly affects balance sheet flexibility while the business works to improve margins and cash conversion.
Yet behind the AI headlines, one underappreciated risk that investors should be aware of is the combination of high leverage and still negative free cash flow…
Read the full narrative on Bausch + Lomb (it’s free!)
Bausch + Lomb’s narrative projects $5.9 billion revenue and $252.2 million earnings by 2028. This requires 5.7% yearly revenue growth and about a $557 million earnings increase from $-305.0 million today.
Uncover how Bausch + Lomb’s forecasts yield a $17.25 fair value, in line with its current price.
The most pessimistic analysts see a tougher path, with revenue at about US$5.8 billion and earnings only US$247.0 million by 2029, reminding you that views on BLCO’s debt burden and efficiency efforts can differ sharply and may shift again after this AI initiative.
Explore 4 other fair value estimates on Bausch + Lomb – why the stock might be worth over 4x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.